140 filings
Page 5 of 7
6-K
27m7d
9 Mar 22
Medicenna Announces Upcoming Poster Presentations at the AACR Annual Meeting
7:15am
6-K
ywsfdtmg29rd f1u
3 Mar 22
Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor
7:10am
6-K
xztphdyt7vd6cy
10 Feb 22
Medicenna to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
7:05am
6-K
5ukxm87ozg towt
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
9ilouu
2 Feb 22
Current report (foreign)
7:32am
6-K
kqakah
31 Jan 22
Medicenna Announces Formation of its Scientific Advisory Board
7:15am
6-K
3mh8zihkkmhwc8
26 Jan 22
Medicenna Announces Peer-Reviewed Publication of Preclinical Data on MDNA11 in the Journal for ImmunoTherapy of Cancer
8:08am
6-K
dr4 3exacmx1ya6lci
18 Jan 22
Medicenna Announces Management Change and Appoints Experienced Development Advisory Committee
7:15am
6-K
asjtx
5 Jan 22
Medicenna to Participate in Upcoming January Investor Conferences
9:07am
6-K
9x6m8x3xtoevuo
22 Dec 21
Current report (foreign)
7:33am
6-K
yjxin6ddkfbqbn
17 Dec 21
Medicenna Receives Regulatory Clearance to Expand the Phase 1/2 ABILITY Study of MDNA11 to Canada
8:00am
6-K
18lvb2xdqklk3
18 Nov 21
Current report (foreign)
7:15am
6-K
qrv3ks5wq1t4nwu
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
9bxe3qnn8 sx
9 Nov 21
Medicenna Therapeutics to Present at Stifel’s Virtual Healthcare Conference
8:23am
6-K
nqkjo3i
4 Nov 21
Current report (foreign)
9:00am
6-K
gyq7z 6uryxhl
27 Oct 21
Medicenna Announces FDA Clearance of IND to Expand the Phase 1/2 ABILITY Study of MDNA11 to the United States
8:22am
6-K
5qxikfb7xku50 h0c
7 Oct 21
Medicenna Presents MDNA11 Data from IND-Enabling Studies at the AACR-NCI-EORTC Conference
9:10am
6-K
7xr polca
23 Sep 21
Medicenna Appoints Dr. John H. Sampson to its Board of Directors
5:28pm
6-K
m0s2uxs12v2pkkb2q08t
22 Sep 21
Medicenna Presenting at Next-Gen Cytokine Therapeutics Summit
10:29am
6-K
ysfls0y6xh b21j
20 Sep 21
Medicenna Announces Issuance of U.S. Patent Providing Added Intellectual Property Protection for its MDNA11 Program
8:16am